Skip to main content
. 2022 Feb 24;28(3):591–598. doi: 10.1038/s41591-022-01707-4

Extended Data Fig. 1. Time-to-event analyses of composite adjudication-confirmed MACE-4.

Extended Data Fig. 1

Data are point estimate of HR (illustrated by the diamond symbol) and range of 2-sided 95% CI of the HR. aStrata size adjusted estimate. Strata are defined as trial-level cardiovascular risk (SURPASS-4 forms one stratum, and all other trials form one stratum). Abbreviations: CI = confidence interval; HR = hazard ratio; iDeg = insulin degludec; iGlar = insulin glargine; MACE = major adverse cardiovascular events; n = number of participants in the specified category; PBO = placebo; TZP = tirzepatide.